Cited by 327Blood Pressure and Hypertension StudiesChronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

The Treatment of Hypertension in Adult Patients With Diabetes

Open access

Arauz-Pacheco, Carlos, Parrott, Marian A., Raskin, Philip·2002·Diabetes Care

DOI 10.2337/diacare.25.1.134

Open this paper in CoChat — free account Open PDF

Abstract

Hypertension is an extremely common comorbidity of diabetes, affecting 20–60% of people with diabetes. Hypertension is also a major risk factor for cardiovascular events, such as myocardial infarction and stroke, as well as for microvascular complications, such as retinopathy and nephropathy. Cardiovascular disease is the most costly complication of diabetes and is the cause of 86% of deaths in persons with diabetes (1). However, until recently, little research had been done specifically in patients with diabetes and hypertension. In reviewing the literature on diabetes and hypertension, the authors searched MEDLINE for English language articles using keywords “hypertension,” “diabetes mellitus,” “diabetic nephropathy,” and “coronary artery disease/prevention” starting from 1966. Before 1996, most available data come from secondary analysis from studies done in the general population of people with hypertension, observing a subset with diabetes. Recent studies have demonstrated the effectiveness of blood pressure treatment versus placebo in reducing complications of diabetes (2,3), helped to define the optimal level of blood pressure control (4,5,6), and compared treatment strategies based on different drug classes (7,8,9,10,11,12,13). The results of these studies support an aggressive approach to the diagnosis and treatment of hypertension in patients with diabetes in order to substantially reduce the incidence of both macrovascular and microvascular complications. ### Definition of hypertension in diabetic populations Epidemiological studies and therapeutic trials have often used different criteria to define hypertension in diabetic patients. Studies in the general population indicate an increased risk of cardiovascular disease with an increase in the level of blood pressure. Thus, an increase in diastolic or systolic blood pressure of 5 mmHg is associated with a concomitant increase in cardiovascular disease of 20–30% (14). Studies in diabetic populations have shown a markedly higher frequency of the progression of diabetic retinopathy …

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/diacare.25.1.134

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
(1998) · BMJ · doi:10.1136/bmj.317.7160.703 · Cited by 6,683
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
MACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253 · cited 1×
“Thus, an increase in diastolic or systolic blood pressure of 5 mmHg is associated with a concomitant increase in cardiovascular disease of 20–30% (14).”
Background
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777

Show all 129 references

Sorted by citations

Items 201–300 of 327

Olmesartan Medoxomil-Based Antihypertensive Therapy Evaluated by Ambulatory Blood Pressure Monitoring
Chrysant, S. G., Germino, F. W., & Neutel, J. M. (2012) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03262472 · Cited by 6
“Also, the risk of CVD (including coronary artery disease, peripheral arterial disease, myocardial infarction, heart failure, and stroke) and renal insufficiency in patients with both diabetes and hypertension is greatly increased.([13]) Other complications in patients with diabetes and hypertension include diabetic ne…”
Background
Hypertension in Nigerians with type 2 diabetes: a multicentre survey
Akhuemokhan, I. K., Ehusani-Anumah, F. O., Ogbera, A. O., Ikem, R. T., Fasanmade, O. A., & Ohwovoriole, A. E. (2008) · Cited by 6
Assessment of mean platelet volume in type 2 diabetics receiving insulin or oral antidiabetic agents
Şahpaz, F., & Ulutaş, K. T. (2015) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/diclemedj.0921.2015.04.0598 · Cited by 6
“Diabetic patients are known to have higher incidence of myocardial infarction and stroke [23].”
Background
Hypertension awareness, treatment, and control among diabetic and nondiabetic individuals in a multiethnic population in the Netherlands
Fernald, F. F., van den Born, B. H., Snijder, M. B., Brewster, L. M., Peters, R. J. G., & Agyemang, C. O. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000820 · Cited by 6
“There is strong evidence that pharmacological treatment of hypertension in patients with diabetes significantly reduces microvascular and macrovascular complications [2,3].”
Background
Diabetes Mellitus: Pathogenesis and Natural History
Skyler, J. S. (2004) · Springer eBooks · doi:10.1007/978-1-4757-4371-5_2 · Cited by 7
A Comparison of the Use of Clinical-Guideline–Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes and Hypertension in the United States: NHANES 2003-2012
Perez, A., Levin, A., & Alam, N. (2016) · The Diabetes Educator · doi:10.1177/0145721716666680 · Cited by 5
Exploiting Multiwavelength Morphological Features of Camera-PPG for Blood Pressure Estimation
Hou, Z., Huang, D., Huang, Y., Huang, J., Zhao, N., Pan, L., Lu, H., Shan, C., & Wang, W. (2025) · IEEE Transactions on Instrumentation and Measurement · doi:10.1109/tim.2025.3551005 · Cited by 6
“Therefore, continuous blood pressure (BP) monitoring is crucial for hypertensive patients in both clinical and home settings, as it aids in timely risk assessment, treatment adjustment, and prevention of complications [3].”
Prevalence of Hypertension and Glycaemic Control in Adult Type-2 Diabetes Patients: A Preliminary Retrospective Cohort Study in Kuantan, Pahang, Malaysia
Abdullah, F., Han, T. M., Nor, M. B. M., Aznan, M., & Ismail, I. Z. (2017) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v16i1.366 · Cited by 5
The IGF‐I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial
Zandbergen, A. A. M., Lamberts, S. W. J., Baggen, M. G. A., Janssen, J. A. M. J. L., Boersma, E. H., & Bootsma, A. H. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02449.x · Cited by 5
Incidence of Cardiovascular Events in Which 2 Thiazolidinediones Are Used as Add-on Treatments for Type 2 Diabetes Mellitus in a Taiwanese Population
Chou, C.-C., Chen, W., Kao, T., Chang, Y., Loh, C., & Wang, C.-C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.10.025 · Cited by 5
Quality of diabetes care in family health facilities in one health district in alexandria.
Fatouh, N. F., & El-Din, M. N. (2009) · PubMed · Cited by 5
Hypertension and diabetes mellitus: a collision of two heavyweight non-communicable diseases
Pillay, S. (2021) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2021.2002585 · Cited by 5
“The prevalence of HPT in DM ranges globally from 40% to 60%.(17,18) Our study showed a much higher prevalence of HPT in PLWD (86.”
Background
Risk of Cardiovascular Outcomes and Antihypertensive Triple Combination Therapy Among Elderly Patients with Hypertension Enrolled in a Medicare Advantage Plan (MAP)
Wang, X., Chen, H., Essien, E. J., Wu, J., Serna, O., Paranjpe, R., & Abughosh, S. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-020-00395-0 · Cited by 6
Diabetes and Cardiovascular Disease
Hill‐Briggs, F., Naqibuddin, M., & Golden, S. H. (2022) · Springer eBooks · doi:10.1007/978-0-387-85960-6_58 · Cited by 5
Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats
Bhadada, S. V., & Goyal, R. K. (2007) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y07-069 · Cited by 5
Hypertension Management in the Diabetes Patient
Durst, S. W., & Schering, D. (2004) · Journal of Pharmacy Practice · doi:10.1177/0897190003261309 · Cited by 5
“Total body sodium is increased, as is the vascular response to vasoconstrictors.(2,3)”
Background
Blood pressure control—Effects on diabetic nephropathy progression: How low does blood pressure have to be?
Newton, C. A., & Raskin, P. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0124-0 · Cited by 5
“In spite of the controversy over whether they provide any additional benefit, ACEIs and angiotensin receptor antagonists remain important to the treatment of diabetic patients and are often recommended as first-line agents in managing hypertension in diabetes [ 46 ].”
BackgroundSelf-citation
Impact of Department of Veterans Affairs Cooperative Studies Program clinical trials on practice guidelines for high blood pressure management
Henrie, A. M., Sather, M. R., Bakhireva, L. N., Nawarskas, J. J., Boardman, K. D., & Huang, G. D. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.100313 · Cited by 5
“The American Diabetes Association [16,17].”
Optimizing blood pressure control in the obese patient
Pischon, T., & Sharma, A. M. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0064-8 · Cited by 5
“Current guidelines recommend optimal blood pressure levels (less than 120/ 80 mm Hg) for patients with type 2 diabetes [3,4, 19 ].”
Background
Mobile Phone Including Smart Phone based Persuasive System Design for controlling Hypertension and Diabetes in Bangladesh
Ghorai, K., Jahan, S., Chylinski, M., & RAY, P. K. (2013) · Journal of the Association for Information Systems · doi:10.13140/2.1.3666.4327 · Cited by 4
Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus
Kaku, K., Enya, K., Sugiura, K., & Totsuka, N. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.630386 · Cited by 4
Treatment of Hypertension in Adults With Diabetes
American Diabetes Association (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.3.122 · Cited by 4
Lipid peroxidation and non-enzymatic antioxidants status in hypertension in diabetic and non-diabetic patients in Nigeria: a comparative study.
Ekeanyanwu, R., Rn, E., & Mc, E. (2016) · Biomedical Research-tokyo · Cited by 4
Adherence to Available Clinical Practice Guidelines for Initiation of Antihypertensive Medication in Patients With or Without Diabetes Mellitus and Other Comorbidities in Taiwan
Chou, C.-C., Lin, W., Kao, T., Chang, Y., & Chen, W. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011398658 · Cited by 4
Influence of antihypertensive therapy and blood pressure control on left ventricular geometry and function in subjects with type II diabetes: The Augsburg Diabetes Family Study
Kuch, B., von Scheidt, W., Peter, W., Heier, M., Wichmann, H. ‐., & Meisinger, C. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002062 · Cited by 4
Hypertensive diabetic patients: guidelines for conduct and their difficulties
Barroso, W. K. S., Jardim, P. C. B. V., Jardim, T. S. V., Souza, C. T. S., Magalhães, A. L. A., Ibrahim, F. M., Couto, P. V. O., Silveira, A., & Mônego, E. T. (2003) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2003001000003 · Cited by 4
Epidemiologic Perspectives of Risk for Developing Diabetes and Diabetes Complications
Berry, D. C., & Melkus, G. D. (2006) · Nursing Clinics of North America · doi:10.1016/j.cnur.2006.07.008 · Cited by 4
Diabetic Hypertension
Khan, K. A., Govindarajan, G., Whaley‐Connell, A. T., & Sowers, J. R. (2006) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.11.002 · Cited by 4
Treating diabetes: cardiovascular benefits of antidiabetes drugs.
Peters, A. L. (2002) · PubMed · Cited by 4
Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring
Kereiakes, D. J., & Neutel, J. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944710378675 · Cited by 3
Assessment of Modifiable Risk Factors Associated With Hypertensive Patients
Awan, M. U. M., Nasir, W., Zafar, S., Mushtaq, H. H., Ullah, A., Hayyat, M., Akram, Z., Tahir, T. B., & Noor, A. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i2.1165 · Cited by 4
Prevention of Coronary Heart Disease
Ghanem, F. A., & Movahed, A. (2008) · Springer eBooks · doi:10.1007/978-3-540-78674-0_36 · Cited by 3
Equal Care, Unequal Outcomes: Experiences of a REACH 2010 Community
Neal, D. E., Carlson, B. A., Jenkins, C. M., & Magwood, G. (2007) · Digital Scholarship - UNLV (University of Nevada Reno) · Cited by 3
Estimate of the diabetic retinopathy hazard rates in type 2 diabetic patients with current status data
Askarishahi, M., Hajizadeh, E., Afkhami‐Ardekani, M., & Manaviat, M. R. (2012) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-012-0092-0 · Cited by 3
“Hypertension is a major risk factor for cardiovascular events, such as myocardial infarction and stroke, as well as for microvascular complications, such as retinopathy and nephropathy [27].”
Background
Treating to target in type 2 diabetes
Keigher, C., Avalos, G., & Dunne, F. (2007) · The British Journal of Diabetes · doi:10.1177/14746514070070020601 · Cited by 3
Serum Malondialdehyde and Lipid Profile Levels of Young Patients "Haven’t a Family History of Hypertension": A New Study for Cases in the Civic Society
Jasim, R. H. (2011) · Pakistan Journal of Chemistry · doi:10.15228/2011.v01.i03.p03 · Cited by 3
Simultaneous determination and estimation of Amlodipine andPerindopril in raw and tablet formulation by stabilityindicating RP-HPLCmethod
Manoharan, G. (2016) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-1105032429 · Cited by 3
“The molecular formula of perindopril arginine and perindopril erbumine is different but their therapeutic action is very similar[6].”
IDENTIFIKASI DRUG RELATED PROBLEMS PADA PASIEN DIABETES MELITUS TIPE II DENGAN KOMPLIKASI HIPERTENSI DI INSTALASI RAWAT INAP RSUD LABUANG BAJI KOTA MAKASSAR PERIODE JANUARI-JUNI 2016
Stevani, H., Sulfiana, S., & Farid, A. M. (2019) · Media Farmasi · doi:10.32382/mf.v13i2.883 · Cited by 3
Is Intensive Management of Blood Pressure to Prevent Visual Loss inPersons With Type 2 Diabetes Indicated?
Klein, R. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1707 · Cited by 3
Massachusetts Guidelines for Adult Diabetes Care
(2009) · State Library's electronic repository (State Library of Massachusetts) · Cited by 3
References
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.62 · Cited by 3
Standards of Medical Care in Diabetes
American Diabetes Association (2005) · Diabetes Care · doi:10.2337/diacare.28.suppl_1.s4 · Cited by 2
Técnicas educacionales en el tratamiento de la diabetes Educational techniques in diabetes treatment
Selli, L., Papaléo, L. K., Meneghel, S. N., & Torneros, J. Z. (2005) · Cited by 2
Transition Specific Risk Factors Affecting the Lifestyle Disease Progression from Diabetes to Hypertension in India
Meitei, W. B., & Ladusingh, L. (2019) · Health · doi:10.4236/health.2019.118083 · Cited by 2
“Diabetes and hypertension are common co-morbid associates and coexist in approximately 40 to 60 percent of patients [12].”
Background
Epidemiology and Pathogenesis of Type 2 Diabetes
Robertson, R. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_3 · Cited by 2
The Effects of Anti-Hypertensive Drugs Evaluated Using Markov Modelling for Northern Ireland Chronic Kidney Disease Patients
Rainey, A., Cairns, K. J., Marshall, A. H., Quinn, M. P., Savage, G., & Fogarty, D. G. (2008) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2008.73 · Cited by 2
“Considering hypertension is one of the main risk factors for CKD, the use of Ace Inhibitors (ACEI) and Antiotensin II Receptor Blocker (ARBs), two forms of AHT, have been proven to slow the progression and development of CKD [ 9 ].”
Background
A study of the development of macrovascular complications and factors related to these complications in young adults with childhood/adolescence-onset type 1 diabetes mellitus
Kang, M. J., Kim, J. H., Chung, H. R., Lee, Y. A., Shin, C. H., Yang, S. W., Kim, Y. Y., Jin, S. M., & Noh, C. I. (2009) · Korean Journal of Pediatrics · doi:10.3345/kjp.2009.52.2.220 · Cited by 2
Management of hypertension in patients with type 2 diabetes mellitus
Mashitisho, M. (2013) · South African Family Practice · doi:10.1080/20786204.2013.10874300 · Cited by 2
Guideline adherence and control of diabetes mellitus with or without co-morbidities in various wards of a tertiary hospital in Malaysia
Iqbal, M. Z., Iqbal, M. S., Nicholas, D., Awang, J., Khan, A. H., & Sulaiman, S. A. S. (2014) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v3i8.19405 · Cited by 2
“The tight control of DM and appropriate management of these co-morbidities is required to increase the quality of life of patients and decrease further complications in patients (Arauz-Pacheco et al., 2002; Heisleret al., 2002).”
Background
Prevalence and Determinants of Comorbid Diabetes and Hypertension in Nepal: Evidence from NCD Risk Factors STEPS Survey Nepal 2013
Pandey, A. R., Karki, K. B., Mehata, S., Aryal, K. K., Thapa, P., Pandit, A., Bista, B., Dhakal, P., & Dhimal, M. (2015) · Journal of Nepal Health Research Council · Cited by 2
Effect of amlodipine on blood glucose level in euglycemic and streptozotocin induced diabetic Albino rats and its pharmacodynamic interaction with glibenclamide
Gari, M., Debbarma, R., Majhee, L., & Choudhury, S. (2017) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20172724 · Cited by 2
Diabetic Glomerulopathy
Barazi, M., Kaur, H., & Prabhakar, S. S. (2011) · InTech eBooks · doi:10.5772/22795 · Cited by 2
Outpatient Diabetic Care in a Public Central Hospital: Patient Characteristics, Therapeutic Regimens and Results
Martins, M. (2014) · Journal of Endocrinology and Metabolism · doi:10.14740/jem205w · Cited by 2
Quality of Chronic Disease (Diabetes & Hypertension) Care in Health Care Facilities in High Disease Burden Areas in Sidama Region: Cross-Sectional Study
Deribe, B., Tadesse, F., Dadi, G. B., Ayalew, M., Borie, Y. A., Alemayehu, T., Aynalem, A., Geja, E., Gebrekidan, M. G., Debiso, A. T., et al. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s451186 · Cited by 2
Serum Caveolin-1 Level is Inversely Associated with Serum Vaspin, Visfatin, and HbA1c in Newly Diagnosed Men with Type-2 Diabetes
Ali, H. H., Al-Rawi, K. F., Khalaf, Y. H., Alaaraji, S. F. T., Aldahham, B. J. M., Awad, M. M., Al-ani, O., Al-Ani, F., & Ali, A. T. (2022) · Reports of Biochemistry and Molecular Biology · doi:10.61186/rbmb.11.2.299 · Cited by 2
Renin angiotensin aldosterone system altered in resistant hypertension in Sub-Saharan African diabetes patients without evidence of primary hyperaldosteronism
EDINGA, B. E., Moor, V. J. A., Nansseu, J. R., Djoumessi, R. N., Mengnjo, M. K., Katte, J.-C. N., Noubiap, J. J., & Sobngwi, E. (2017) · JRSM Cardiovascular Disease · doi:10.1177/2048004017695006 · Cited by 2
“Hypertension and diabetes coexist in 40 to 60% of type 2 diabetes patients.(4,5) Diabetes patients have been shown to have a 1.”
Background
Behavioral Counseling Interventions for Primary Prevention of Coronary Heart Disease in Individuals with Type-2 Diabetes
Egede, L. E. (2004) · Comprehensive Therapy · doi:10.1007/s12019-004-0010-6 · Cited by 2
NUTRITIONAL RELATED LIFESTYLE OF TYPE 2 DIABETIC PATIENTS IN AHVAZ-I.R. IRAN
Amani, R., & Mostafavi, A. (2006) · Intern J Endocrinol Metab · Cited by 1
Tratamiento de la hipertensión arterial en los diabéticos: una revisión crítica
García, F. M., Ortiz, A. G., & Alonso, M. J. M. (2007) · Medicina de Familia SEMERGEN · doi:10.1016/s1138-3593(07)73886-8 · Cited by 1
Tratamiento de la hipertensión en los pacientes diabéticos
Xavier, H. T. (2008) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(08)75788-7 · Cited by 1
Use of a treatment algorithm did not improve blood pressure control in primary care patients with type 2 diabetes
Opsteen, C. (2007) · Evidence-Based Nursing · doi:10.1136/ebn.10.4.121 · Cited by 1
Tratamiento de la hipertensión arterial en el paciente con diabetes mellitus tipo 2
Rodríguez-Carranza, S. I., & Aguilar-Salinas, C. A. (2006) · Revista de Endocrinología y Nutrición · Cited by 1
PREVALENCE OF PREHYPERTENSION AMONG ADULTS ATTENDING RURAL COMMUNITY HEALTH CENTRE, SOUTH KERALA , INDIA
C, V. M. M., & K, S. S. R. M. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/325 · Cited by 1
Evaluation of Prescribing Trends in Ambulatory Cardiac Patients above 50 Years of Age in Lahore, Pakistan
Bukhsh, A. (2014) · Advances in Pharmaceutical and Ethnomedicines · doi:10.14737/journal.ape/2014/2.2.26.31 · Cited by 1
Longitudinal Evaluation and Meta-analysis of Clinical Articles on the Antihypertensive Effects of Incretin-related Drugs
Iijima, H., & Kamei, M. (2017) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.43.201 · Cited by 1
Blood Pressure Lowering and Microvascular Complications of Diabetes
Cohen, S. D., & Faselis, C. J. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_19 · Cited by 1
Antihypertensive effect of Dapagliflozin in Type II diabetic patients with Hypertension
Hammoud, S., Boubou, A., & Kaddar, N. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00128 · Cited by 1
Avanços Terapêuticos e Estratégias de Gestão para Doenças Crônicas Não Transmissíveis: Uma Análise das Abordagens Inovadoras no Tratamento de Diabetes, Hipertensão e Doenças Cardíacas
da Cunha, L. V., Silva, N. S., Chaves, M. V. D. M., de Castro, T. G., & Bertoldi, G. T. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n5p609-622 · Cited by 1
A review of anti-hypertension therapies in diabetic patients.
Ogochukwu, A. M., & Victoria, U. C. (2010) · Europe PMC (PubMed Central) · Cited by 1
Screening for Chronic Complications in Type 1 Diabetes
Dorsey, R. R. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
RENAL FUNCTION IMPAIRMENT IN INSULIN DEPENDENT AND NON INSULIN DEPENDENT DIABETIC PATIENTS
Mohammad, R., Hassan, M., & Wahab, A. (2015) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v5i1.731 · Cited by 1
Outpatient Diabetic Care in a Public Central Hospital: Patient Characteristics, Therapeutic Regimens and Results
Martins, J. M., Vale, S., Martins, A., Gomes, A. R., Vicente, L., & Caldeira, J. (2014) · Journal of Endocrinology and Metabolism · doi:10.14740/jem.v4i1-2.205 · Cited by 1
“Pharmacological treatment of HBP and/or nephropathy seems adequately prescribed; however, half of the patients were under monotherapy and this may fall off the target [4, 53].”
Background
Gasto farmacéutico en diabetes mellitus en una región de España según el Clinical Risk Group, 2012
Estrada, L. A., Vivas-Consuelo, D., Caballer-Tarazona, V., Usó-Talamantes, R., Mestre, C. S., & Buigues-Pastor, L. (2016) · Gerencia y Políticas de Salud · doi:10.11144/javeriana.rgyps15-30.gfdm · Cited by 1
“La prevalencia de esta comorbilidad concuerda con lo reportado a nivel mundial en la población diabética (18).”
Background
A Study of Drug Use in Type 2 Diabetes Mellitus with and Without CoMorbidities in Patients Visiting A Tertiary Care Hospital
Patil, D. V. N. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i5.30 · Cited by 1
Hypertension in Non‐Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors
Janghorbani, M., Aminorroaya, A., & Amini, M. (2017) · International Journal of Hypertension · doi:10.1155/2017/3132729 · Cited by 1
Relationships between the diabetes awareness and clinical indices/nutrient intakes in Korean adults: Based on the 2012–2013 Korea National Health and Nutrition Examination Survey Data
Lee, S., Park, H., Lee, Y., Choi, O., Kim, J., Gray, H. L., & Song, K. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.3.240 · Cited by 1
“Strict blood pressure control can reduce the mortality and delay complications such as diabetic retinopathy and reduced vision [22].”
Background
Effect of Saffron supplementation and exercise training on blood pressure, pulmonary function and spirometery indicators in obese and overweight women affected by type 2 diabetes
Rajabi, A., Akbarnejad, A., Siahkouhian, M., & Yari, M. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Diabetes Mellitus
Alicic, R. Z., & Tuttle, K. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42973-3.00037-8 · Cited by 1
Estudio comparativo de prevalencia del gen de la ECA en muestras de diabéticos y población general
Fernández, M., Acosta, M., Airaudo, C., Fernández, J., Ferrero, R., Javiel, G., Pena, A., Simonelli, B., Soto, E., Vitarella, G., et al. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
ESTUDIO DE PEQUEÑOS PÉPTIDOS (<1500 Da) CON ACTIVIDAD ANTIHIPERTENSIVA Y ANTIOXIDANTE GENERADOS EN EL JAMÓN CURADO
FERNÁNDEZ, M. E. E. (2012) · doi:10.4995/thesis/10251/18237 · Cited by 1
“Hypertension is one of the major risk factors for the development of cardiovascular diseases, stroke, and end-stage renal disease [7].”
Background
Development of a Smartphone-enabled hypertension and diabetes management package to facilitate evidence-based care delivery in primary healthcare facilities in India: A formative research to inform intervention design
Sarala, A. (2014) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · doi:10.17037/pubs.02021055 · Cited by 1
Genomics and Translational Biology Interdisciplinary Working Group and Outcomes Research Interdisciplinary Working Group; and Functional Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care Association Councils on Epidemiology and Prevention, Clinical Cardiology, Prevention of Heart Failure. A Scientific Statement From the American Heart
Hong, Y., Levy, D. A., Mensah, G. A., Narula, J., Stuart‐Shor, E., Young, J. B., Schocken, D. D., Benjamin, E. J., Fonarow, G. C., & Krumholz, H. M. (2008) · Cited by 1
Deben ser tratadas la hipertensión y la diabetes por los cardiólogos
Hernández‐Vargas, H. (2002) · Cited by 1
DIABETES IN PREGNANCY
Catalano, P. M. (2000) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200003000-00001 · Cited by 1
Efecto del té de peña, Sideritis hyssopifolia, en el desarrollo y evolución de la aterosclerosis en conejos
Alcaraz, E. C. (2014) · doi:10.18002/10612/4224
Factors that affect Glycaemic Control among Type 2 Diabetes Mellitus Patients in Kwahu South District Eastern Region, Ghana
Tengey, J. (2012)
Utilization and costs of prescription medication in patients with type 1 diabetes: Impact of diabetic kidney disease
Lithovius, R. (2015) · Työväentutkimus Vuosikirja
Contribuição do tratamento com fármacos Anti-Hipertensores para a Resistência à Insulina na Diabetes Mellitus
Monteiro, A. C. D. R. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Inhibition of the renin-angiotensin system in normotensive type 2 diabetes: effects and mechanisms of action
Zandbergen, A. A. M. (2007) · EUR Research Repository (Erasmus University Rotterdam)
The role of the sympathetic nervous system in the pathomechanism and the therapy of hypertension
Légrády, P. (2014) · doi:10.14232/phd.2145
The effect of self-management program on blood pressure control in hypertensive patients at risk for stroke
Thutsaringkarnsakul, S. (2011) · NRCT Data Center · doi:10.14457/cu.the.2011.1254
Cyclic Relationships Between Diabetic Nephropathy and Cardiovascular Risk Factors
Charles, M., & Selam, J. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.203
“73,79 It is no wonder that ACE inhibitors also have been shown to reduce CV event rates and death in diabetes.”
Management of hypertension in diabetes mellitus
Alzahrani, A. S. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.341
Treatment of hypertension reduces risk of complications in type 2 diabetes
Weinger, K., & Rosenzweig, J. L. (2003) · Evidence-Based Nursing · doi:10.1136/ebn.6.4.109
Insulin stimulates monocyte membrane associated tissue factor activity
Bhatt, B. A., Patel, D. R., Kristol, D. S., Arora, R. R., & Spillert, C. R. (2003) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.2003.1216089
Increased night/day diastolic blood pressure ration is associated with high normal urinary albumin excretion and retinopathy in normotensive and normoalbuminuric type 1 diabetic patients
Duvnjak, L. S., Rogulja-Pepeonik, Ž., Car, N., & Metelko, Ž. (2005) · Diabetologia Croatica
Benefits of hypertension management in diabetes: An opportunity not to be missed
Narkiewicz, K., Oparil, S., Kjeldsen, S. E., & Hedner, T. (2008) · Blood Pressure · doi:10.1080/08037050802636105
“If therapeutic blood pressure goals are to be achieved in diabetics, many patients will need two or more drugs (11).”
Background
Approach to arterial hypertension in patients with diabetes mellitus.
Duvnjak, L. S., MoHan-Sepuri, K., Car, N., & Metelko, Ž. (2004) · Diabetologia Croatica
The prevalence and management of hypertension in a population of adults with type 2 diabetes in the Adamawa Region (Cameroon): A retrospective analysis
Mbouemboue, O. P. (2012) · International Journal of Medicine and Medical Sciences · doi:10.5897/ijmms12.052
Évaluation des pratiques en hospitalisation programmée d'endocrinologie au centre hospitalier de Chambéry sur une population de diabétiques de type 2 : atteinte à un an des objectifs fixés et adéquation aux recommandations de l'HAS
Martin, J., & Bouvier, J.-B. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)

Authors: Arauz-Pacheco, C., Parrott, M. A., & Raskin, P.
Affiliations: George Washington University (US)
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2002-01-01
Volume: 25
Issue: 1
Pages: 134-147
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.25.1.134
OpenAlex: W2138299277
Cited by: 326
References: 129
Citations by year: 2026: 2 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 11 · 2019: 8 · 2018: 4 · 2017: 14 · 2016: 14 · 2015: 15 · 2014: 16 · 2013: 12 · 2012: 19
FWCI: 4.04
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: hypertension, diabetes mellitus, antihypertensive therapy, blood pressure control, diabetic nephropathy, diabetic retinopathy, cardiovascular complications, microvascular complications, antihypertensive drug classes
MeSH terms: Adult, Diabetic Angiopathies, Female, Humans, Hypertension, Lactation, Pregnancy, Pregnancy in Diabetics, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Treatment of Hypertension in Adult Patients With Diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks